3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
5
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Pancreatic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity
2
Meningioma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Surgical Wound Dehiscence
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Interventions
aldesleukin
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
talazoparib
1
liposomal doxorubicin
1
fludarabine
1
dostarlimab
1
belzutifan
1
apixaban
1
Vaccines, Synthetic
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Rivaroxaban
1
Radiotherapy
1
Radiation
1
Papillomavirus Vaccines
1
Paclitaxel
1
Observation
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Imiquimod
1
Hysterectomy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Heparin, Low-Molecular-Weight
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Vaginal Neoplasms
×
Observation
×
Clear all
NCT06514235
2025-08-19
EMBRAVE
Erasmus Medical Center
Recruiting
300 enrolled